Nataliya G Batina1, Christoper J Crnich2, David F Anderson3, Dörte Döpfer4. 1. Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI. Electronic address: ngbatina@gmail.com. 2. Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI; Department of Medicine, University of Wisconsin-Madison, Madison, WI; William S. Middleton Veterans Affairs Hospital, Madison, WI. 3. Department of Mathematics, University of Wisconsin-Madison, Madison, WI. 4. Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI; Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI.
Abstract
BACKGROUND: Recent spread of USA300 methicillin-resistant Staphylococcus aureus (MRSA) to nursing homes has been of particular concern. We sought to predict the ultimate prevalence of USA300 and non-USA300 MRSA and to examine the influence of potential risk factors on MRSA acquisition in community nursing homes. METHODS: The data were collected during a longitudinal MRSA surveillance study that involved 449 residents in 6 community nursing homes in Wisconsin. The subjects were screened every 3 months for up to 1 year. Markov chain models were employed to predict strain-specific prevalence of MRSA at steady state, and to assess the influence of potential risk factors, including recent hospitalizations, invasive medical devices, and antibiotic exposure on MRSA acquisition rates and average duration of colonization. RESULTS: At steady state, 20% (95% confidence interval [CI], 15%-25%) of residents were predicted to remain colonized with non-USA300 and 4% (95% CI, 2%-7%) with USA300 MRSA. Residents who used antibiotics during the previous 3 months were twice more likely to acquire MRSA than those who did not (acquisition rates, 0.052; 95% CI, 0.038-0.075 and 0.025; 95% CI, 0.018-0.037, respectively). CONCLUSIONS: Non-USA300 was predicted to remain the dominant MRSA strain in community nursing homes. The higher rate of MRSA acquisition among residents with recent antibiotic exposure suggests that antibiotic stewardship may reduce MRSA colonization in this setting.
BACKGROUND: Recent spread of USA300 methicillin-resistant Staphylococcus aureus (MRSA) to nursing homes has been of particular concern. We sought to predict the ultimate prevalence of USA300 and non-USA300 MRSA and to examine the influence of potential risk factors on MRSA acquisition in community nursing homes. METHODS: The data were collected during a longitudinal MRSA surveillance study that involved 449 residents in 6 community nursing homes in Wisconsin. The subjects were screened every 3 months for up to 1 year. Markov chain models were employed to predict strain-specific prevalence of MRSA at steady state, and to assess the influence of potential risk factors, including recent hospitalizations, invasive medical devices, and antibiotic exposure on MRSA acquisition rates and average duration of colonization. RESULTS: At steady state, 20% (95% confidence interval [CI], 15%-25%) of residents were predicted to remain colonized with non-USA300 and 4% (95% CI, 2%-7%) with USA300 MRSA. Residents who used antibiotics during the previous 3 months were twice more likely to acquire MRSA than those who did not (acquisition rates, 0.052; 95% CI, 0.038-0.075 and 0.025; 95% CI, 0.018-0.037, respectively). CONCLUSIONS: Non-USA300 was predicted to remain the dominant MRSA strain in community nursing homes. The higher rate of MRSA acquisition among residents with recent antibiotic exposure suggests that antibiotic stewardship may reduce MRSA colonization in this setting.
Authors: Sara E Cosgrove; Youlin Qi; Keith S Kaye; Stephan Harbarth; Adolf W Karchmer; Yehuda Carmeli Journal: Infect Control Hosp Epidemiol Date: 2005-02 Impact factor: 3.254
Authors: Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield Journal: JAMA Date: 2003-12-10 Impact factor: 56.272
Authors: B S Cooper; G F Medley; S P Stone; C C Kibbler; B D Cookson; J A Roberts; G Duckworth; R Lai; S Ebrahim Journal: Proc Natl Acad Sci U S A Date: 2004-06-25 Impact factor: 11.205
Authors: Christy Cassarly; Renee' H Martin; Marc Chimowitz; Edsel A Peña; Viswanathan Ramakrishnan; Yuko Y Palesch Journal: Commun Stat Simul Comput Date: 2016-09-23 Impact factor: 1.118
Authors: Melissa G Edmondson; Christopher D Heaney; Meghan F Davis; Gurumurthy Ramachandran Journal: J Occup Environ Hyg Date: 2022-02-22 Impact factor: 2.155
Authors: Nataliya G Batina; Christopher J Crnich; David F Anderson; Dörte Döpfer Journal: Antimicrob Resist Infect Control Date: 2016-09-22 Impact factor: 4.887
Authors: Monica da Silveira; Maria de Lourdes Ribeiro de Souza da Cunha; Camila Sena Martins de Souza; Adriana Aparecida Feltrin Correa; Carlos Magno Castelo Branco Fortaleza Journal: Ann Clin Microbiol Antimicrob Date: 2018-05-04 Impact factor: 3.944